Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E7YK
|
||||
Former ID |
DNC014636
|
||||
Drug Name |
(R)-5-Amino-3-(4-chloro-phenyl)-pentanoic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C11H14ClNO2
|
||||
Canonical SMILES |
C1=CC(=CC=C1C(CCN)CC(=O)O)Cl
|
||||
InChI |
1S/C11H14ClNO2/c12-10-3-1-8(2-4-10)9(5-6-13)7-11(14)15/h1-4,9H,5-7,13H2,(H,14,15)/t9-/m1/s1
|
||||
InChIKey |
QXAGSDSDBMVSQR-SECBINFHSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid B receptor | Target Info | Inhibitor | [1] | |
KEGG Pathway | cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
GABAergic synapse | |||||
Estrogen signaling pathway | |||||
Morphine addiction | |||||
Reactome | Activation of G protein gated Potassium channels | ||||
G alpha (i) signalling events | |||||
Class C/3 (Metabotropic glutamate/pheromone receptors) | |||||
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | |||||
WikiPathways | GPCRs, Class C Metabotropic glutamate, pheromone | ||||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
Potassium Channels | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | J Med Chem. 1999 Jun 3;42(11):2053-9.Synthesis and pharmacology of the baclofen homologues 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorophenyl)pentanoicacid. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.